Epidemiology of inflammatory bowel disease among children in Poland. A prospective, population-based, 2-year study,

Katarzyna Karolewska-Bochenek1, Izabella Lazowska-Przeorek, Piotr Albrecht

  • 1Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, Ul. Dzialdowska 1, PL-01-184 Warsaw, Poland. kasiabochenek@hotmail.com

Digestion
|March 27, 2009
PubMed

Insights

The incidence of pediatric inflammatory bowel disease (IBD) in Poland is lower than in Western countries, with a higher relative proportion of ulcerative colitis (UC) and indeterminate colitis (IC). Further research may be needed to explore potential underdiagnosis.

Area of Science:

  • Pediatric Gastroenterology
  • Epidemiology
  • Inflammatory Bowel Disease Research

Background:

  • Pediatric inflammatory bowel disease (IBD) incidence is increasing globally.
  • No prior prospective epidemiological studies on pediatric IBD in Poland existed.
  • This study addresses the need for data on pediatric IBD in Poland.

Purpose of the Study:

  • To determine the incidence of new pediatric IBD cases in Poland.
  • To characterize new pediatric IBD diagnoses between 2002 and 2004.
  • To compare Polish pediatric IBD rates with those in Western countries.

Main Methods:

  • Data collected from 24 pediatric gastroenterology centers nationwide.
  • Diagnosis of IBD confirmed through clinical, radiological, endoscopic, and histological evaluations.
  • Analysis of patient records for new IBD diagnoses.

Main Results:

  • Overall pediatric IBD incidence was 2.7 cases/100,000 children/year.
  • Crohn's disease (CD) incidence: 0.6; ulcerative colitis (UC): 1.3; indeterminate colitis (IC): 0.8.
  • Incidence higher in adolescents (3.7/100,000) than younger children (1.8/100,000).

Conclusions:

  • Pediatric IBD incidence in Poland is lower than in Western nations.
  • UC and IC constitute a larger proportion of IBD cases in Poland compared to Western countries.
  • Findings suggest potential underdiagnosis or misdiagnosis of pediatric IBD in Poland.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...